Mohamed Awwad
Group Leader Heidelberg University Hospital
Seminars
Thursday 26th February 2026
Standardising CAR T-Cell Monitoring to Improve Clinical Insights & Translational Outcomes
11:30 am
- Highlight approaches to monitor CAR T-cells consistently during production and in patients
- Explore how monitoring informs therapy development, safety, and efficacy assessments
- Discuss the potential for standardised monitoring to guide clinical decisions and improve outcomes
Tuesday 24th February 2026
Panel Discussion: Current Efforts to Spearhead Regulatory Modernisation & Acceptance of Novel CGT Technologies
11:00 am
- Share how regulators in Europe, the US, and Asia are adapting frameworks to keep pace with emerging cell and gene therapy technologies
- Highlight initiatives that foster earlier and more constructive engagement
- Understand how modernisation efforts can accelerate approvals, support broader adoption, and make CGTs more commercially viable
